$RSLS
ReShape Lifesciences Inc.

2023 Q4 Form 10-Q Financial Statement

#000155837023018344 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $1.982M $2.155M
YoY Change -36.27% -22.98%
Cost Of Revenue $140.0K $867.0K
YoY Change -90.73% 24.39%
Gross Profit $1.842M $1.288M
YoY Change 15.13% -38.7%
Gross Profit Margin 92.94% 59.77%
Selling, General & Admin $2.998M $1.791M
YoY Change -48.88% -31.62%
% of Gross Profit 162.76% 139.05%
Research & Development $739.0K $542.0K
YoY Change 67.57% -7.82%
% of Gross Profit 40.12% 42.08%
Depreciation & Amortization $14.00K $40.00K
YoY Change -97.28% -92.63%
% of Gross Profit 0.76% 3.11%
Operating Expenses $3.737M $5.168M
YoY Change -40.74% -63.16%
Operating Profit -$1.895M -$3.880M
YoY Change -59.73% -67.47%
Interest Expense $114.0K $5.000K
YoY Change -31.33% -83.87%
% of Operating Profit
Other Income/Expense, Net $114.0K $0.00
YoY Change 5600.0%
Pretax Income -$1.667M -$3.531M
YoY Change -89.89% -71.0%
Income Tax $31.00K $3.000K
% Of Pretax Income
Net Earnings -$1.698M -$3.534M
YoY Change -89.78% -70.08%
Net Earnings / Revenue -85.67% -163.99%
Basic Earnings Per Share -$1.02
Diluted Earnings Per Share -$0.11 -$1.02
COMMON SHARES
Basic Shares Outstanding 13.14M 3.452M
Diluted Shares Outstanding 3.453M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.459M $1.400M
YoY Change 15.67% -77.22%
Cash & Equivalents $4.459M $1.449M
Short-Term Investments
Other Short-Term Assets $126.0K $94.00K
YoY Change 50.0% -40.13%
Inventory $3.741M $3.204M
Prepaid Expenses
Receivables $1.700M $2.200M
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.30M $7.399M
YoY Change 3.88% -45.49%
LONG-TERM ASSETS
Property, Plant & Equipment $60.00K $70.00K
YoY Change -91.4% -92.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $29.00K $29.00K
YoY Change -36.96% -97.62%
Total Long-Term Assets $367.0K $428.0K
YoY Change -70.19% -97.12%
TOTAL ASSETS
Total Short-Term Assets $10.30M $7.399M
Total Long-Term Assets $367.0K $428.0K
Total Assets $10.66M $7.827M
YoY Change -4.3% -72.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.689M $1.462M
YoY Change -12.31% -26.61%
Accrued Expenses $1.814M $2.734M
YoY Change -64.01% -43.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.777M $4.469M
YoY Change -49.51% -40.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $223.0K $300.0K
YoY Change
Total Long-Term Liabilities $223.0K $300.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.777M $4.469M
Total Long-Term Liabilities $223.0K $300.0K
Total Liabilities $4.000M $4.744M
YoY Change -46.53% -36.86%
SHAREHOLDERS EQUITY
Retained Earnings -$635.6M -$633.9M
YoY Change 1.83% 4.54%
Common Stock $23.00K $3.000K
YoY Change 2200.0% -86.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.663M $3.083M
YoY Change
Total Liabilities & Shareholders Equity $10.66M $7.827M
YoY Change -4.3% -72.49%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.698M -$3.534M
YoY Change -89.78% -70.08%
Depreciation, Depletion And Amortization $14.00K $40.00K
YoY Change -97.28% -92.63%
Cash From Operating Activities -$2.460M -$2.780M
YoY Change -13.07% -47.27%
INVESTING ACTIVITIES
Capital Expenditures $3.000K $0.00
YoY Change -96.2% -100.0%
Acquisitions
YoY Change
Other Investing Activities $3.000K $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.464M -340.0K
YoY Change 756.43% -11433.33%
NET CHANGE
Cash From Operating Activities -2.460M -2.780M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 5.464M -340.0K
Net Change In Cash 3.004M -3.120M
YoY Change -232.28% -41.15%
FREE CASH FLOW
Cash From Operating Activities -$2.460M -$2.780M
Capital Expenditures $3.000K $0.00
Free Cash Flow -$2.463M -$2.780M
YoY Change -15.33% -46.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001427570
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3452841
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
519219
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-37897
dei Entity Registrant Name
EntityRegistrantName
RESHAPE LIFESCIENCES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1828101
dei Entity Address Address Line1
EntityAddressAddressLine1
18 Technology Dr, Suite 110
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
429-6680
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
RSLS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13135478
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1449000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3855000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
100000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
100000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
859000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
410000
CY2023Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2153000
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2180000
CY2023Q3 us-gaap Inventory Net
InventoryNet
3204000
CY2022Q4 us-gaap Inventory Net
InventoryNet
3611000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
493000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
165000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
7399000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
9911000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
698000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
274000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
171000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
55000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
56000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
260000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
46000
CY2023Q3 us-gaap Assets
Assets
7827000
CY2022Q4 us-gaap Assets
Assets
11142000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1462000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1926000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2734000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5040000
CY2023Q3 rsls Warrant Liability Current
WarrantLiabilityCurrent
163000
CY2022Q4 rsls Warrant Liability Current
WarrantLiabilityCurrent
344000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
110000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
171000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4469000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7481000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
175000
CY2023Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
100000
CY2023Q3 us-gaap Liabilities
Liabilities
4744000
CY2022Q4 us-gaap Liabilities
Liabilities
7481000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3452841
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
519219
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
3000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
637050000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
627935000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-633876000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-624187000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-94000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-88000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3083000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3661000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7827000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11142000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2155000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2798000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6696000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8130000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
867000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
697000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2990000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2928000
CY2023Q3 us-gaap Gross Profit
GrossProfit
1288000
CY2022Q3 us-gaap Gross Profit
GrossProfit
2101000
us-gaap Gross Profit
GrossProfit
3706000
us-gaap Gross Profit
GrossProfit
5202000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1791000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2605000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6150000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11936000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2058000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3784000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8724000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13037000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
542000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
583000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1576000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2075000
CY2023Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
777000
CY2022Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
7429000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
777000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
7429000
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-383000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
5168000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
14402000
us-gaap Operating Expenses
OperatingExpenses
17194000
us-gaap Operating Expenses
OperatingExpenses
34860000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3880000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12301000
us-gaap Operating Income Loss
OperatingIncomeLoss
-13488000
us-gaap Operating Income Loss
OperatingIncomeLoss
-29658000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
31000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
47000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-412000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3850000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-68000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-279000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-47000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-467000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3531000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12549000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9668000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30069000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-363000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-324000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3534000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12186000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9689000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29745000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-27.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-27.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-73.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-73.79
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3452672
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3452672
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
451202
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
451202
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2809748
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2809748
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
403122
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
403122
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3534000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-12186000
us-gaap Net Income Loss
NetIncomeLoss
-9689000
us-gaap Net Income Loss
NetIncomeLoss
-29745000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
24000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
24000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3533000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12182000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-657000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-307000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1317000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
329000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-696000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2764000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-51000
rsls Increase Decrease In Warrant Liability
IncreaseDecreaseInWarrantLiability
-182000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9695000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29721000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6738000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3534000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
216000
CY2023Q3 rsls Adjustments To Additional Paid In Capital Stock Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockOfferingCosts
-338000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3083000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3661000
us-gaap Net Income Loss
NetIncomeLoss
-9689000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
895000
rsls Adjustments To Additional Paid In Capital Stock Offering Costs
AdjustmentsToAdditionalPaidInCapitalStockOfferingCosts
-247000
rsls Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
7813000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3083000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
30776000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-12186000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
359000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
18953000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44334000
us-gaap Net Income Loss
NetIncomeLoss
-29745000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
24000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1848000
rsls Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
2492000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
18953000
us-gaap Profit Loss
ProfitLoss
-9689000
us-gaap Profit Loss
ProfitLoss
-29745000
us-gaap Depreciation
Depreciation
114000
us-gaap Depreciation
Depreciation
271000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1367000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
777000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
7429000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-383000
us-gaap Share Based Compensation
ShareBasedCompensation
656000
us-gaap Share Based Compensation
ShareBasedCompensation
1847000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
450000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-72000
us-gaap Inventory Write Down
InventoryWriteDown
101000
us-gaap Inventory Write Down
InventoryWriteDown
148000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-368000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3850000
rsls Offering Cost
OfferingCost
298000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-12000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
21000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
422000
rsls Increase Decrease In Warrant Liability
IncreaseDecreaseInWarrantLiability
-297000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-17000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14503000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19073000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
43000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
52000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
33000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
39000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12451000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
338000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2492000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12113000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2492000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-6000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2406000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16570000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3955000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22815000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1549000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6245000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
79000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1500000
CY2023Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.5pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:27pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may materially differ from these estimates. The Company reviews its estimates on an ongoing basis or as new information becomes available to ensure that these estimates appropriately reflect changes in its business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12.25pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">​</span></p>
CY2023Q3 rsls Working Capital
WorkingCapital
2900000
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
902000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
832000
CY2023Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
1053000
CY2022Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
864000
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1249000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1915000
CY2023Q3 us-gaap Inventory Net
InventoryNet
3204000
CY2022Q4 us-gaap Inventory Net
InventoryNet
3611000
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
259000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
78000
CY2023Q3 rsls Prepaid Patent Expense Current
PrepaidPatentExpenseCurrent
38000
CY2023Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
47000
CY2022Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
3000
CY2023Q3 us-gaap Prepaid Taxes
PrepaidTaxes
55000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
94000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
84000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
493000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
165000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1014000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1829000
CY2023Q3 rsls Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
400000
CY2022Q4 rsls Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
1775000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
657000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
510000
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
54000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
119000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
504000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
316000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
105000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
491000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2734000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5040000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6451000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6191000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
260000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
16000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
100000
us-gaap Operating Lease Cost
OperatingLeaseCost
300000
us-gaap Operating Lease Cost
OperatingLeaseCost
600000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
274000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
171000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
110000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
171000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
175000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
285000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
171000
us-gaap Operating Lease Payments
OperatingLeasePayments
201000
us-gaap Operating Lease Payments
OperatingLeasePayments
473000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
27000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
111000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
115000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
59000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
312000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
27000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
285000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.069
CY2023Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
672
CY2022Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
2321
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
2340
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
20505
CY2023Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
3.07
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.07
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2155000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2798000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6696000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8130000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
216000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
359000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
656000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1847000

Files In Submission

Name View Source Status
rsls-20230930_cal.xml Edgar Link unprocessable
rsls-20230930_def.xml Edgar Link unprocessable
0001558370-23-018344-index-headers.html Edgar Link pending
0001558370-23-018344-index.html Edgar Link pending
0001558370-23-018344.txt Edgar Link pending
0001558370-23-018344-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rsls-20230930.xsd Edgar Link pending
rsls-20230930x10q.htm Edgar Link pending
rsls-20230930xex31d1.htm Edgar Link pending
rsls-20230930xex31d2.htm Edgar Link pending
rsls-20230930xex32d1.htm Edgar Link pending
rsls-20230930xex32d2.htm Edgar Link pending
Show.js Edgar Link pending
rsls-20230930_lab.xml Edgar Link unprocessable
rsls-20230930_pre.xml Edgar Link unprocessable
rsls-20230930x10q_htm.xml Edgar Link completed